✓ No active regulatory warningsFDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
📰Read the full Coenzyme Q10 evidence review on GMJ News →Complete clinical article, references and updates on news.gmj.ge. This page is the structured safety summary.⚠ Statin patient with persistent myalgia — trial of CoQ10 100–200 mg/day is reasonable [8]
⚠ Heart failure patient — Q-SYMBIO showed mortality benefit at 300 mg/day; discuss with cardiologist [5]
⚠ Warfarin patient starting CoQ10 — structurally similar to vitamin K; check INR within 1–2 weeks [3]
⚠ Child with steroid-resistant nephrotic syndrome or cerebellar ataxia — consider primary CoQ10 deficiency [4]
⚠ PD patient asking about CoQ10 — QE3 trial showed no benefit; redirect to evidence-based therapies [6]
ℹ️ Not obtained from food. Made by the body and present in small amounts in food; there is no established daily dietary target.
☑ Risk checker
Statin therapy (inhibits mevalonate pathway, reducing CoQ10 synthesis by 20–40%) [2]
Aging (endogenous synthesis declines after age 30–40) [3]
Heart failure (increased utilization, reduced tissue levels) [5]
Primary CoQ10 deficiency (autosomal recessive mutations in COQ genes) [4]
Mitochondrial disorders [4]
Select factors
🔬 Lab interpreter
Recommended test
Plasma CoQ10 (total ubiquinone + ubiquinol)
Plasma CoQ10 (total ubiquinone + ubiquinol)
Reference range / target
>1.0 µg/mL (therapeutic); >2.0 µg/mL (some cardiology targets)
>1.0 µg/mL (therapeutic); >2.0 µg/mL (some cardiology targets)
Plasma CoQ10 reflects supplementation status, not tissue status. Levels rise with supplementation and return to baseline within 2 weeks of stopping [3].
Full lab monitoring ↓⚕ For professionals — confirm ranges against your local laboratory.
Clinical verdict
CoQ10 is a critical mitochondrial electron carrier whose synthesis is reduced 20–40% by statins. Q-SYMBIO trial showed 43% MACE reduction in heart failure at 300 mg/day. No benefit proven for Parkinson disease (QE3 trial). Ubiquinol is 2–3× more bioavailable than ubiquinone. Take with fat-containing meals. Monitor INR if on warfarin [2] [5] [6].
1 How much do I need?
👤 Adults: Specific dosage data under clinical review
👴 Elderly: Specific dosage data under clinical review
🤰 Pregnancy: See guidance
No established RDA. Small trials suggest possible preeclampsia prevention benefit. Generally considered safe at 100–200 mg/day, but data are limited. Consult obstetric provider [3].
👦 Pediatric: See guidance
Primary CoQ10 deficiency presenting in childhood (nephrotic syndrome, cerebellar ataxia, encephalomyopathy) is treated with 5–30 mg/kg/day — early treatment can prevent irreversible organ damage [
🏃 Athletes: Standard dose
⚖️ Obesity: Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
🩺 Renal: Consult specialist
Dose adjustment may be needed in renal impairment.
🌱 Vegan: Standard dose
How to take
🍽 Timing: Take with a meal containing fat — absorption improves 3-fold with food vs fasting [3].
💊 With food: Take with the largest meal of the day or a meal containing olive oil, nuts, or avocado [3].
2 Which form?
| Form | Bioavailability | Vegan | Cost |
|---|---|---|---|
| ['Ubiquinone (oxidized CoQ10)', 'common', 'Standard supplemental form. Must be reduced to ubiquinol in the body to function as an antioxidant. Well-studied. Lower cost [1].'] | Standard | Check label | |
| ['Ubiquinol (reduced CoQ10)', 'preferred', 'The bioactive, reduced form. Approximately 2–3× greater bioavailability than ubiquinone. May be preferred in elderly or individuals with impaired reduction capacity (heart failure, liver disease) [3].'] | Standard | Check label | |
| ['Solubilized/nano-formulations', '', 'Various formulations using cyclodextrin, liposomes, or oil-based soft gels to enhance absorption. Bioavailability varies by product [3].'] | Standard | Check label |
3 Common questions
Should I take CoQ10 if I'm on a statin? ▼
This is the most common question and remains debated. Statins do reduce CoQ10 synthesis by 20–40% [2]. Some meta-analyses suggest CoQ10 modestly reduces statin-related muscle symptoms, but results are inconsistent [8]. There is no universal guideline recommending routine CoQ10 with statins. It is reasonable to try 100–200 mg/day if experiencing statin-related muscle symptoms.
Is ubiquinol better than ubiquinone? ▼
Ubiquinol (the reduced form) has approximately 2–3× greater bioavailability than ubiquinone [3]. It may be preferred in elderly patients, heart failure, or those not responding to ubiquinone. However, both forms are converted back and forth in the body, and ubiquinone is well-studied and effective in clinical trials (including Q-SYMBIO, which used ubiquinone).
Does CoQ10 help heart failure? ▼
The Q-SYMBIO trial (n = 420) showed 43% reduction in MACE and 42% reduction in mortality with 300 mg/day over 2 years [5]. This is the strongest clinical trial evidence. However, it was a single trial and not yet replicated at scale. Current ESC/AHA heart failure guidelines do not formally recommend CoQ10, but some cardiologists use it as adjunctive therapy.
Can CoQ10 treat Parkinson disease? ▼
Despite early promise, the definitive QE3 Phase III trial (n = 600) showed no benefit of CoQ10 at any dose (1,200 or 2,400 mg/day) versus placebo for early Parkinson disease [6]. It is not recommended for this indication.
4 Clinical evidence
Strong
Essential role in mitochondrial electron transport chain — genetic primary CoQ10 deficiency causes encephalomyopathy, nephrotic syndrome, and cerebellar ataxia, treated with high-dose CoQ10 supplementation [4]. Statins inhibit CoQ10 synthesis via mevalonate pathway suppression — this is well-established biochemically [2]. HIGH
Moderate
Heart failure: the Q-SYMBIO trial (n = 420, randomized, double-blind) showed that CoQ10 300 mg/day reduced major adverse cardiovascular events by 43% and all-cause mortality by 42% over 2 years [5]. Statin-associated myopathy: meta-analysis of 12 RCTs showed modest reduction in statin-related muscle symptoms with CoQ10 supplementation, though results are inconsistent [8]. Migraine prevention: a small RCT (n = 42) showed CoQ10 300 mg/day reduced migraine frequency by 48% vs 14% placebo [3]. Preeclampsia prevention: a small trial showed reduced risk with CoQ10 supplementation from 20 weeks gestation [3]. MODERATE
Insufficient
Parkinson disease: the QE3 Phase III trial (n = 600) found no benefit of CoQ10 at 1,200 or 2,400 mg/day vs placebo for early PD [6]. Athletic performance in healthy individuals: no convincing benefit [3]. Male fertility: some positive small studies but insufficient for recommendation [3]. Huntington disease: no benefit in Phase III trial [3]. LOW
5 Safety, toxicity & adverse events
Relative
⚠ Concurrent warfarin — CoQ10 has structural similarity to vitamin K; may reduce INR (monitor closely)
⚠ Concurrent antihypertensives — CoQ10 may lower blood pressure 11/7 mmHg (additive)
⚠ Concurrent chemotherapy — theoretical concern about antioxidant protection of tumor cells (discuss with oncologist)
⚠ Concurrent insulin/sulfonylureas — CoQ10 may improve insulin sensitivity (monitor glucose)
🚩 Red flags
● Warfarin patient starting CoQ10 — check INR within 1–2 weeks (structural similarity to vitamin K) [3]
● Child with steroid-resistant nephrotic syndrome — consider primary CoQ10 deficiency (genetic testing) [4]
● Patient attributing statin intolerance solely to CoQ10 depletion and refusing statins — important to distinguish myalgia from true myopathy; statins save lives [2]
6 Interactions
Drug interactions
Warfarin Major
Mechanism: CoQ10 (ubiquinone) is structurally similar to vitamin K₂. May promote coagulation and reduce warfarin efficacy. [3]
Effect: Reduced INR. Potential thromboembolic events if warfarin dose is not adjusted. [3]
Action: Check INR within 1–2 weeks of starting CoQ10. Monitor closely with dose changes [3].
Statins (atorvastatin, rosuvastatin, etc.) Moderate
Mechanism: Statins inhibit HMG-CoA reductase (mevalonate pathway), reducing endogenous CoQ10 synthesis by 20–40%. [2]
Effect: Reduced plasma CoQ10. Possible contribution to statin myopathy. [2]
Action: CoQ10 100–200 mg/day is reasonable if statin-associated muscle symptoms occur [8].
Antihypertensives Minor
Mechanism: CoQ10 may have modest blood pressure lowering effects (meta-analyses suggest ~3–5 mmHg systolic reduction). [3]
Effect: Additive blood pressure reduction; risk of hypotension in patients on multiple antihypertensives. [3]
Action: Monitor blood pressure, especially during dose adjustments [3].
Chemotherapy agents (doxorubicin) Moderate
Mechanism: Doxorubicin causes cardiotoxicity partly via mitochondrial damage and ROS. CoQ10 is cardioprotective in animal models. [1]
Effect: Potential cardioprotection. Theoretical concern about reducing chemotherapy efficacy (antioxidant interference), though clinical data are limited. [1]
Action: Discuss with oncologist before supplementing during chemotherapy [1].
Supplement synergies
Vitamin E · 15 mg/day vitamin E (RDA)
CoQ10 regenerates oxidized vitamin E (alpha-tocopherol) back to its active form, and both protect cell membranes from lipid peroxidation [1].
CoQ10 regenerates oxidized vitamin E (alpha-tocopherol) back to its active form, and both protect cell membranes from lipid peroxidation [1].
Selenium · 100–200 µg/day selenium
The KiSel-10 trial showed that combined selenium + CoQ10 supplementation (200 µg Se + 200 mg CoQ10) reduced cardiovascular mortality by 49% in elderly Swedish adults over 5 years [3].
The KiSel-10 trial showed that combined selenium + CoQ10 supplementation (200 µg Se + 200 mg CoQ10) reduced cardiovascular mortality by 49% in elderly Swedish adults over 5 years [3].
Alpha-Lipoic Acid · 300–600 mg/day ALA
Both are mitochondrial antioxidants. ALA regenerates CoQ10 in the mitochondrial membrane [1].
Both are mitochondrial antioxidants. ALA regenerates CoQ10 in the mitochondrial membrane [1].
7 Regulatory
United States (FDA): Classified as a dietary supplement. No RDA established (endogenously synthesized). No FDA-approved health claims. Marketed for heart health and energy [1].
European Union (EFSA): No authorized health claims. Classified as a food supplement. Widely available OTC across Europe [3].
Japan (MHLW): CoQ10 was a prescription drug in Japan until 2001 (for heart failure). Now available as a food supplement. One of the most popular supplements in Japan [3].
South Korea (MFDS): Available as dietary supplement. Approved claims: antioxidant activity.
8 US supplement products
43
on-market products containing Coenzyme Q10 (NIH DSLD)
Brands carrying Coenzyme Q10 (16)
Click a brand to see its Coenzyme Q10 products.
9 Frequently paired with
10 Cite this page
Vancouver: Pkhakadze G. Coenzyme Q10 — safety profile [Internet]. Tbilisi: PHIG; 2026 [cited 2026 Jul 12]. Available from: https://supplement.ge/ingredients/coenzyme-q10/
APA 7th: Pkhakadze, G. (2026). Coenzyme Q10 — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/coenzyme-q10/
📋 Editorial information
Author: Prof. G. Pkhakadze, MD, MPH, PhD
Institution: Public Health Institute of Georgia (PHIG)
Affiliation: David Tvildiani Medical University (DTMU)
First published: January 2026
Last reviewed: 2026-05-29
Next review: January 2027
References: 8 cited sources
COI: SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
Process: Systematic literature review
📄 License & reuse
Published under Creative Commons Attribution 4.0 International (CC BY 4.0). You may share and adapt for any purpose with attribution.
Pkhakadze G. "Coenzyme Q10 — Safety Profile." SupplementIndex, PHIG, 2026. https://supplement.ge/ingredients/coenzyme-q10/ CC BY 4.0.
GP
Prof. G. Pkhakadze, MD, MPH, PhD
Professor of Public Health · Head of Department, DTMU
Editor-in-Chief, Georgian Medical Journal (ISSN 3088-4322)
Chair, Public Health Institute of Georgia · UEMS Public Health Section
Educational and public health purposes. CC BY 4.0. Consult your healthcare provider before starting any supplement. Corrections: info@accreditation.ge. Publisher: PHIG